Arbutus Biopharma press release (ABUS): Q1 GAAP EPS of $0.87. – Revenue of $179.1M.
Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna